Ariston Holding N.V. (E0E.F)
EUR 3.56
(-0.89%)
EUR 3.56
(-0.89%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 282.1 Million | 128.5 Million | 190.5 Million | 248.2 Million | 193.76 Million |
| Net Income | 191.2 Million | 140.3 Million | 136.5 Million | 96.7 Million | 89.01 Million |
| Depreciation & Amortization | 131.4 Million | 89.8 Million | 75.8 Million | 77.7 Million | 74.37 Million |
| Deferred income taxes | -9.9 Million | -1.7 Million | -25.6 Million | -4.2 Million | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -108.5 Million | -134.8 Million | -38.3 Million | 40.6 Million | 9.4 Million |
| Other non-cash items | 404.5 Million | 330.3 Million | 207 Million | 156.5 Million | 20.96 Million |
| Investing Cash Flow | -709.9 Million | -133.8 Million | -84.7 Million | -67.9 Million | -222.24 Million |
| Investments in PPE | -158.6 Million | -78.6 Million | -78.1 Million | -44.5 Million | -84.21 Million |
| Acquisitions | -546.4 Million | -24.9 Million | 1.4 Million | 3.5 Million | 4.4 Million |
| Investment purchases | -4.9 Million | -30.3 Million | -8 Million | -26.9 Million | -144.32 Million |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | -100 Thousand | -1.9 Million | 100 Thousand | 200 Thousand | -13.85 Million |
| Financing Cash Flow | -102 Million | 324.5 Million | 102.1 Million | -29.9 Million | 27.23 Million |
| Debt repayment | -41.6 Million | -394.1 Million | -132 Million | -100.2 Million | -72.85 Million |
| Dividends payments | -48.3 Million | -46.4 Million | -48.3 Million | -128.6 Million | -30.79 Million |
| Common Stock Repurchased | -8.7 Million | -12.5 Million | - | - | - |
| Common Stock Issuance | - | - | 294 Million | - | - |
| Other Financing Activities | -500 Thousand | -8.8 Million | -10.2 Million | -6.9 Million | -14.82 Million |
| Accounts receivables | -5.3 Million | -21.2 Million | -17.5 Million | 1.3 Million | -12.2 Million |
| Accounts payables | -26.2 Million | -27 Million | 112.3 Million | 38.3 Million | - |
| Inventory | -32.29 Million | -67.6 Million | -108.1 Million | -3.3 Million | 27.35 Million |
| Other working capital | -44.7 Million | -19 Million | -25 Million | 4.3 Million | -5.75 Million |
| Cash at beginning of period | 999.3 Million | 689.7 Million | 452.5 Million | 295.8 Million | - |
| Cash at end of period | 451.2 Million | 999.3 Million | 689.7 Million | 452.5 Million | -1.25 Million |
| Capital Expenditure | -158.6 Million | -78.6 Million | -78.1 Million | -44.5 Million | -84.21 Million |
| Effect of forex changes on cash | -7.8 Million | 2.8 Million | 16.9 Million | -15.4 Million | - |
| Net cash flow / Change in cash | -548.1 Million | 309.6 Million | 237.2 Million | 156.7 Million | -1.25 Million |
| Free Cash Flow | 123.5 Million | 49.9 Million | 112.4 Million | 203.7 Million | 109.55 Million |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -31.9 Million | 89.6 Million | 191.2 Million | 101.6 Million | 73.9 Million | 140.3 Million |
| Depreciation & Amortization | 68 Million | 75.3 Million | 131.4 Million | 56.1 Million | 45.7 Million | 89.8 Million |
| Deferred income taxes | - | -9.9 Million | -9.9 Million | - | -1.7 Million | -1.7 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -45.6 Million | 77.21 Million | -108.5 Million | -185.71 Million | 26.4 Million | -134.8 Million |
| Other non-cash items | 209.4 Million | 111.39 Million | 404.5 Million | 293.11 Million | 106.3 Million | 330.3 Million |
| Investing Cash Flow | -49.8 Million | -131.5 Million | -709.9 Million | -578.4 Million | -59.5 Million | -133.8 Million |
| Investments in PPE | -28.2 Million | -128.1 Million | -158.6 Million | -30.5 Million | -59.1 Million | -78.6 Million |
| Acquisitions | -18.79 Million | - | -546.4 Million | -546.4 Million | -23 Million | -24.9 Million |
| Investment purchases | -2.8 Million | -3.5 Million | -4.9 Million | -1.4 Million | 22.7 Million | -30.3 Million |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -100 Thousand | - | - | -1.9 Million |
| Financing Cash Flow | -160.6 Million | 85.3 Million | -102 Million | -187.3 Million | 380.8 Million | 324.5 Million |
| Debt repayment | -96.9 Million | -98.1 Million | -41.6 Million | -139.7 Million | -397.5 Million | -394.1 Million |
| Dividends payments | -63.1 Million | - | -48.3 Million | -48.3 Million | - | -46.4 Million |
| Common Stock Repurchased | - | -8.7 Million | -8.7 Million | - | -12.5 Million | -12.5 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 1.1 Million | -2.3 Million | -500 Thousand | 1.8 Million | -3.2 Million | -8.8 Million |
| Accounts receivables | 15 Million | 10.8 Million | -5.3 Million | -16.1 Million | -1.7 Million | -21.2 Million |
| Accounts payables | -87.6 Million | -6.2 Million | -26.2 Million | -20 Million | -6 Million | -27 Million |
| Inventory | 21.6 Million | 84.3 Million | -32.29 Million | -116.6 Million | 26.2 Million | -67.6 Million |
| Other working capital | 5.4 Million | -11.69 Million | -44.7 Million | -33 Million | 7.9 Million | -19 Million |
| Cash at beginning of period | 451.2 Million | 225.5 Million | 999.3 Million | 999.3 Million | 515 Million | 689.7 Million |
| Cash at end of period | 248.5 Million | 451.2 Million | 451.2 Million | 225.5 Million | 999.3 Million | 999.3 Million |
| Capital Expenditure | -28.2 Million | -128.1 Million | -158.6 Million | -30.5 Million | -59.1 Million | -78.6 Million |
| Effect of forex changes on cash | - | - | -7.8 Million | - | - | 2.8 Million |
| Net cash flow / Change in cash | -202.7 Million | 225.7 Million | -548.1 Million | -773.8 Million | 484.3 Million | 309.6 Million |
| Free Cash Flow | -15.3 Million | 153.8 Million | 123.5 Million | -30.3 Million | 118.6 Million | 49.9 Million |
MRUS
4093
RELINFRA
MEDCL
HMS
7417